Calendar

Date TBD

RECRUITINGphase readoutNCT07368777: Comparison of Genotype-Based Dietary Counseling Versus Standard Dietary Counseling on Weight Loss and Fat Mass Reduction

Sponsor: Metropolitan College. Phase: NA. Conditions: Overweight, Overweight and Obesity, Adiposity

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07684677: Effect of Participating in a Study of Causes of Pregnancy Loss on Mental Health Outcomes: A Target Trial Emulation Using the COPL Cohort and Danish National Registries

Sponsor: Amager Hospital. Phase: NA. Conditions: Pregnancy Loss, Early, Major Depression, Anxiety, Stress (Psychology)

full page →ctgov ↗

COMPLETEDphase readoutNCT03485677: Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3

Sponsor: Sanofi. Phase: PHASE3. Conditions: Gaucher's Disease Type I, Gaucher's Disease Type III

full page →ctgov ↗

COMPLETEDphase readoutNCT05608577: RE-BLEED: A Digital Platform for Identifying Bleeding Patients - a Feasibility Study

Sponsor: University of Oxford. Phase: . Conditions: Hemorrhage, Trauma, Gastro Intestinal Bleeding

full page →ctgov ↗

RECRUITINGphase readoutNCT07566377: Cord Blood Transplantation in Children and Young Adults With Blood Cancer

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Leukemia, Lymphoma, Graft-versus-host Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT04892277: CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/Refractory B Cell Malignancies

Sponsor: Mayo Clinic. Phase: PHASE1. Conditions: Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Small Lymphocytic Lymphoma, Refractory Transformed Chronic Lymphocytic Leukemia

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06933875: Promoting Palliative Care for People With Heart Failure

Sponsor: Yale University. Phase: NA. Conditions: Heart Failure, Palliative Care

full page →ctgov ↗

RECRUITINGphase readoutNCT07615257: Managing Psychological Distress Through Mindfulness-based CBT to Evaluate Its Effectiveness on Self-compassion Among Psoriasis Patients:The Mediating Role of Mental Health Locus of Control

Sponsor: Islamia University of Bahawalpur. Phase: NA. Conditions: Psoriasis

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06087757: Clemastine Treatment in Individuals With Williams Syndrome

Sponsor: Sheba Medical Center. Phase: PHASE2. Conditions: Williams Syndrome

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05994001: Candonilimab in Combination With LM-302 for Claudin 18.2 Positive-advanced Biliary Tract Cancer After Failure of Standard of Chemotherapy and PD1/PD-L1 Antibody

Sponsor: Shanghai Zhongshan Hospital. Phase: PHASE1. Conditions: Biliary Tract Cancer, Candonilimab, Claudin 18.2

full page →ctgov ↗

COMPLETEDphase readoutNCT06957301: Intrathecal Fentanyl and Dexmedetomidine Added to Bupivacaine for Subarachnoid Anaesthesia for Percutaneous Nephrolithotomy

Sponsor: Alexandria University. Phase: NA. Conditions: Percutaneous Nephrolithotomy (PCNL)

full page →ctgov ↗

COMPLETEDphase readoutNCT06533501: Leucine Requirements During the Menstrual Cycle

Sponsor: University of British Columbia. Phase: NA. Conditions: Menstrual Cycle

full page →ctgov ↗

RECRUITINGphase readoutNCT05608681: A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).

Sponsor: Eupraxia Pharmaceuticals Inc.. Phase: PHASE1. Conditions: Eosinophilic Esophagitis

full page →ctgov ↗

RECRUITINGphase readoutNCT03588481: IRIS- DESyne X2 in the IRIS-DES Registry

Sponsor: Seung-Jung Park. Phase: . Conditions: Coronary Stenosis, Coronary Occlusion, Coronary Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT06558981: Adjuvant Radiotherapy in High Risk Locally Advanced DTC

Sponsor: Fudan University. Phase: PHASE3. Conditions: Thyroid Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06183281: Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Chronic Pain

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07647081: The Impacts of Ashwagandha Supplementation on Diurnal Cortisol and Stress Among Women

Sponsor: Oklahoma State University Center for Health Sciences. Phase: NA. Conditions: Stress

full page →ctgov ↗

COMPLETEDphase readoutNCT07470619: Meditation for Chemotherapy-Induced Nausea and Vomiting in Women With Breast Cancer

Sponsor: Near East University, Turkey. Phase: NA. Conditions: Nausea and Vomiting Chemotherapy-Induced, Meditation Training

full page →ctgov ↗

WITHDRAWNphase readoutNCT03730467: Puncture Breast Abscess

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Breast Abscess

full page →ctgov ↗

RECRUITINGphase readoutNCT04093167: Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer

Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Lung Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT05235867: Secretin in Refeeding

Sponsor: University of California, Los Angeles. Phase: . Conditions: Anorexia in Adolescence

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07464067: Family Planning Methods Among Women in Assuit Egypt

Sponsor: Assiut University. Phase: . Conditions: Family Planning

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03839667: Intensive Diet and Physical Activity on Diabetes

Sponsor: Shanghai Jiao Tong University School of Medicine. Phase: NA. Conditions: Type2 Diabetes, Life Style

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03439267: Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events

Sponsor: Intermountain Health Care, Inc.. Phase: NA. Conditions: Cardiovascular Primary Prevention Strategy

full page →ctgov ↗

RECRUITINGphase readoutNCT03144167: Study of Prognostic Biomarkers of Survival at 6 Months for Patients Treated With Bevacizumab Glioblastomas in First Relapse After Failure of Radiochemotherapy

Sponsor: Centre Hospitalier Universitaire, Amiens. Phase: NA. Conditions: Glioblastoma, Radiotherapy, Chemotherapy

full page →ctgov ↗

COMPLETEDphase readoutNCT05372367: A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Solid Tumors

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT03467867: A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL

Sponsor: Georgetown University. Phase: PHASE2. Conditions: Chronic Lymphocytic Leukemia

full page →ctgov ↗

RECRUITINGphase readoutNCT06633900: Naltrexone for Overdose Prevention

Sponsor: University of California, San Francisco. Phase: PHASE2. Conditions: Overdose Accidental

full page →ctgov ↗

RECRUITINGphase readoutNCT06611007: Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment

Sponsor: University Hospital, Grenoble. Phase: PHASE1. Conditions: Osteoarthritis

full page →ctgov ↗

RECRUITINGphase readoutNCT06970392: Brief Sleep Intervention for Bedtime Resistance

Sponsor: Oregon Health and Science University. Phase: NA. Conditions: Child Sleep

full page →ctgov ↗

RECRUITINGphase readoutNCT07220720: POSLUMA® (18F-rhPSMA-7.3) PET-CT for PIRADS 2/3 Lesions

Sponsor: University of Florida. Phase: PHASE2. Conditions: Prostate

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07453420: Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.

Sponsor: Shalvata Mental Health Center. Phase: . Conditions: Anxiety, Depression - Major Depressive Disorder, Bipolar, Schizophenia Disorder

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07384520: Thrombus Composition in Cerebral Infarctions: Study of Its Association With Plasma Biomarkers, Treatment Efficacy, Etiology and Prognosis.

Sponsor: François Delvoye. Phase: . Conditions: Ischemic Stroke, Cerebral Veinous Thrombosis

full page →ctgov ↗

COMPLETEDphase readoutNCT06792123: Effect of Virtual Reality Application Applied to Patients With Total Knee Replacement at Different Times

Sponsor: Özge İşeri. Phase: NA. Conditions: Anxiety, Recovery Quality

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06912659: The BALANCE Study: A Study in Spain to Find Out Whether a Patient Support Program Helps People With Pulmonary Fibrosis Who Take Nintedanib

Sponsor: Boehringer Ingelheim. Phase: . Conditions: Pulmonary Fibrosis

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT05462262: Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population

Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital. Phase: NA. Conditions: Coronary Artery Disease Progression

full page →ctgov ↗

COMPLETEDphase readoutNCT06001346: CBT+ for Depression

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Major Depressive Disorder

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07469488: A Clinical Trial on the Outcomes of Comprehensive Enhanced Prophylaxis Management (CEPM) in Chinese Patients With EGFR-Mutated Advanced NSCLC Receiving Amivantamab-Based Regimens

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China. Phase: PHASE4. Conditions: NSCLC (Advanced Non-small Cell Lung Cancer), VTE (Venous Thromboembolism), Rash Due to Epidermal Growth Factor Receptor Inhibitors, Infusion Reaction

full page →ctgov ↗

RECRUITINGphase readoutNCT07245888: ClusterVAP: Multicentre Proteomic Endotyping of Ventilator-associated Pneumonia

Sponsor: Region Skane. Phase: . Conditions: Ventilator Acquired Pneumonia, Mechanical Ventilation Complication

full page →ctgov ↗

TERMINATEDphase readoutNCT03211988: Entinostat Neuroendocrine (NE) Tumor

Sponsor: Antonio Fojo. Phase: PHASE2. Conditions: Neuroendocrine Tumors

full page →ctgov ↗

TERMINATEDphase readoutNCT05083403: HPI (Hypotension Prediction Index) Care Trial

Sponsor: Edwards Lifesciences. Phase: NA. Conditions: Cardiopulmonary Bypass Surgery

full page →ctgov ↗

RECRUITINGphase readoutNCT06033027: Arm Use With Soft-robotic Glove

Sponsor: Roessingh Research and Development. Phase: NA. Conditions: Trauma Injury of Hand Multiple, Neurologic Disorder

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02897427: Throat and Other HPV-Related Cancers in Men: Identifying Them Early

Sponsor: Baylor College of Medicine. Phase: . Conditions: Human Papillomavirus Infection

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07413627: A Study Evaluating the Contribution of Non-Coplanar Beam Arrangement in Reducing Toxicity in Radiotherapy for Upper Aerodigestive Tract Cancers

Sponsor: Centre Georges Francois Leclerc. Phase: NA. Conditions: Squamous Cell Carcinoma of the Oral Cavity and Oropharynx

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06070961: Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 Maintenance

Sponsor: Fondazione Italiana Linfomi - ETS. Phase: . Conditions: Follicular Lymphoma

full page →ctgov ↗

RECRUITINGphase readoutNCT05933161: A Study of Glycemic Control in Left Ventricular Assist

Sponsor: Mayo Clinic. Phase: . Conditions: Type 2 Diabetes Mellitus, Hyperglycemia, Hypoglycemia

full page →ctgov ↗

RECRUITINGphase readoutNCT06008561: Midwest Birth Outcomes and Indigenous American Pregnancy

Sponsor: Sanford Health. Phase: . Conditions: Pregnancy

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04491942: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma, Advanced Endometrial Carcinoma, Advanced Esophageal Carcinoma, Advanced Gastric Carcinoma, Advanced Head and Neck Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Advanced Lung Small Cell Carcinoma, Advanced Malignant Solid Neoplasm, Advanced Ovarian Carcinoma, Advanced Penile Carcinoma, Advanced Pleural Malignant Mesothelioma, Advanced Urothelial Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Gastric Cancer AJCC v8, Clinical Stage IV Gastric Cancer AJCC v8, Stage III Cervical Cancer AJCC v8, Stage III Distal Bile Duct Cancer AJCC v8, Stage III Intrahepatic Bile Duct Cancer AJCC v8, Stage III Lung Cancer AJCC v8, Stage III Ovarian Cancer AJCC v8, Stage III Penile Cancer AJCC v8, Stage III Pleural Diffuse Malignant Mesothelioma AJCC v8, Stage IV Cervical Cancer AJCC v8, Stage IV Distal Bile Duct Cancer AJCC v8, Stage IV Intrahepatic Bile Duct Cancer AJCC v8, Stage IV Lung Cancer AJCC v8, Stage IV Ovarian Cancer AJCC v8, Stage IV Penile Cancer AJCC v8, Stage IV Pleural Diffuse Malignant Mesothelioma AJCC v8, Triple-Negative Breast Carcinoma, Unresectable Urothelial Carcinoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06565442: Feasibility of Using NeuraSignal Transcranial Doppler Robot

Sponsor: University of Alabama at Birmingham. Phase: . Conditions: Cerebral Autoregulation

full page →ctgov ↗

RECRUITINGphase readoutNCT07542886: A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin (Somatropin) Delivery and Taken up Into the Blood in Healthy Adults

Sponsor: Pfizer. Phase: PHASE1. Conditions: Healthy

full page →ctgov ↗

Date TBD